Toll Free: 1800 103 1369 Email Us:customercare@canmoney.in

Markets

Market

Income Statement

You can view the Income Statement for the last 5 years.

INCOME STATEMENT

Aarey Drugs & Pharmaceuticals Ltd.

GO
Market Cap. ( ₹ in Cr. ) 149.43 P/BV 1.12 Book Value ( ₹ ) 46.93
52 Week High/Low ( ₹ ) 75/31 FV/ML 10/1 P/E(X) 31.92
Book Closure 30/09/2024 EPS ( ₹ ) 1.65 Div Yield (%) 0.00
(₹ in Crs.)

ParticularsMar 24Mar 23Mar 22Mar 21Mar 20
Months1212121212
Source Of Info (AR = Annual Report, PR = Press Release)ARARARARAR
FaceValue10.0010.0010.0010.0010.00
      
      
INCOME     
Revenue From Operations [Net]395.62418.96492.68348.42300.09
Total Operating Revenues395.62418.96492.68348.42300.09
      
Other Income6.962.732.757.016.69
Total Revenue402.58421.69495.43355.43306.78
      
EXPENSES     
Purchase Of Stock-In Trade387.76418.98467.29339.25285.93
Changes In Inventories Of FG,WIP And Stock-In Trade-5.86-15.144.78-1.464.25
Employee Benefit Expenses0.720.810.980.400.40
Finance Costs4.382.872.002.431.79
Depreciation And Amortisation Expenses1.701.571.990.920.89
Other Expenses8.556.588.375.596.28
Total Expenses397.24415.68485.40347.13299.54
      
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax5.346.0110.038.307.24
      
Profit/Loss Before Tax5.346.0110.038.307.24
      
Tax Expenses-Continued Operations     
Current Tax1.321.782.611.661.50
Deferred Tax-0.67-0.04-0.110.12-0.05
Tax For Earlier Years0.000.500.980.000.00
Total Tax Expenses0.662.243.481.791.45
Profit/Loss After Tax And Before ExtraOrdinary Items4.683.776.546.515.79
      
Profit/Loss From Continuing Operations4.683.776.546.515.79
      
Profit/Loss For The Period4.683.776.546.515.79
      
OTHER INFORMATION     
      
EARNINGS PER SHARE     
Basic EPS (Rs.)1.671.492.722.792.48
Diluted EPS (Rs.)1.671.492.722.792.80